Overactive bladder
Overactive bladder in children
6
Iranian Version of Overactive Bladder Symptom Scale: A Methodological Study
5
Treatment of overactive bladder in the aging population: focus on darifenacin
8
Overactive bladder: strategies to ensure treatment compliance and adherence
6
Urogynecological conditions associated with overactive bladder symptoms in women
5
Translating Overactive Bladder Questionnaires in Moroccan Arabic Dialect
13
Sacral neuromodulation in overactive bladder: a review and current perspectives
7
Overactive bladder, differential diagnosis, and clinical utility of fesoterodine
9
Botulinum toxin therapy for nonneurogenic overactive bladder: first experience
7
Profile of mirabegron in the treatment of overactive bladder: place in therapy
5
Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
8
Oxybutynin extended release for the management of overactive bladder: a clinical review
11
Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective
6
Urinary bladder hypertrophy and overactive bladder determine urinary continence after radical prostatectomy
9
Overactive bladder: the importance of tailoring treatment to the individual patient
5
New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
10
Update on tolterodine extended-release for treatment of overactive bladder
7
Emerging treatments for overactive bladder: clinical potential of botulinum toxins
7
Update on the management of overactive bladder: patient considerations and adherence
11
Characterization of overactive bladder in women in a primary care setting
6